twenty-three patients with relapsed lymphomas resistant to standard chemotherapy , 13 with hodgkin 's disease and 10 with non-hodgkin 's lymphomas , were treated with etoposide 120 mg/m2 i.v . daily for 5 days or orally for 7-10 days , repeated 3-weekly .
C0024299
lymphomas
C0019829
hodgkin 's disease